SIGNIFICANT AND SUSTAINED FLORBETAPIR F18 UPTAKE REDUCTION IN PATIENTS WITH SYMPTOMATIC ALZHEIMER’S DISEASE WITH LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY